Variant report
Variant | esv3506318 |
---|---|
Chromosome Location | chr13:51067351-51076949 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:51065916..51068221-chr13:51075145..51077143,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RNASEH2B-3 | chr13:51067608-51067670 | NONHSAT033856 |
2 | lnc-RNASEH2B-3 | chr13:51076948-51077016 | XLOC_010390 |
3 | lnc-RNASEH2B-3 | chr13:51069312-51069605 | NONHSAT033856 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000176124 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567020203 | chr13:51067371-51067372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186988126 | chr13:51067383-51067384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369115445 | chr13:51067408-51067409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190669140 | chr13:51067415-51067416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34666611 | chr13:51067420-51067421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573847035 | chr13:51067422-51067423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575862983 | chr13:51067461-51067462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540096993 | chr13:51067537-51067538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376732106 | chr13:51067539-51067540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558071212 | chr13:51067572-51067573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551702202 | chr13:51067600-51067601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571559947 | chr13:51067618-51067619 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs75096218 | chr13:51067701-51067702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544143733 | chr13:51067766-51067767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369775493 | chr13:51067773-51067774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149871 | chr13:51067809-51067810 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs562209585 | chr13:51067850-51067851 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141731598 | chr13:51067868-51067869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146001888 | chr13:51068010-51068011 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11619931 | chr13:51068045-51068046 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs180735827 | chr13:51068144-51068145 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548231890 | chr13:51068165-51068166 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs111817012 | chr13:51068232-51068233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560179401 | chr13:51068267-51068268 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527527993 | chr13:51068287-51068288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140050341 | chr13:51068288-51068289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567057780 | chr13:51068306-51068307 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537511337 | chr13:51068373-51068374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549387056 | chr13:51068396-51068397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554035855 | chr13:51068400-51068401 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571175402 | chr13:51068410-51068411 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560825093 | chr13:51068420-51068421 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536383355 | chr13:51068453-51068454 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1262776 | chr13:51068476-51068477 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs76308757 | chr13:51068524-51068525 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1262775 | chr13:51068575-51068576 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs142061616 | chr13:51068578-51068579 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75543472 | chr13:51068591-51068592 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531040208 | chr13:51068610-51068611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544673184 | chr13:51068613-51068614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575724039 | chr13:51068638-51068639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562882314 | chr13:51068641-51068642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146291784 | chr13:51068667-51068668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9316499 | chr13:51068705-51068706 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs560426188 | chr13:51068708-51068709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200695367 | chr13:51068755-51068756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1262774 | chr13:51068896-51068897 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs528633600 | chr13:51068952-51068953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560116776 | chr13:51068958-51068959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1262773 | chr13:51068985-51068986 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hereditary prostate cancer | 22028916 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Prostate cancer | 17217626 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21990379 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:51065600-51068600 | Weak transcription | HepG2 | liver |
2 | chr13:51067200-51068000 | Enhancers | Dnd41 | blood |
3 | chr13:51067600-51069400 | Enhancers | Fetal Thymus | thymus |
4 | chr13:51067800-51068000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr13:51067800-51068200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
6 | chr13:51067800-51068400 | Enhancers | K562 | blood |
7 | chr13:51067800-51069000 | Enhancers | Primary hematopoietic stem cells | blood |
8 | chr13:51067800-51069200 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr13:51067800-51069200 | Enhancers | Thymus | Thymus |
10 | chr13:51068000-51068200 | Flanking Active TSS | Dnd41 | blood |
11 | chr13:51068000-51068600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
12 | chr13:51068000-51068600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr13:51068000-51069200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr13:51068000-51069400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
15 | chr13:51068200-51068400 | Enhancers | Dnd41 | blood |
16 | chr13:51068200-51068800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr13:51068200-51069200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr13:51068200-51069200 | Enhancers | Primary T cells from cord blood | blood |
19 | chr13:51068400-51068600 | Flanking Active TSS | Dnd41 | blood |
20 | chr13:51068400-51068800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
21 | chr13:51068600-51070000 | Enhancers | Dnd41 | blood |
22 | chr13:51069000-51069400 | Enhancers | Adipose Nuclei | Adipose |
23 | chr13:51075000-51075400 | Enhancers | Thymus | Thymus |
24 | chr13:51075000-51075800 | Enhancers | Primary monocytes fromperipheralblood | blood |
25 | chr13:51075000-51075800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
26 | chr13:51075000-51075800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
27 | chr13:51075200-51075800 | Enhancers | K562 | blood |
28 | chr13:51075400-51083400 | Weak transcription | Thymus | Thymus |
29 | chr13:51075800-51084800 | Weak transcription | K562 | blood |